scispace - formally typeset
R

Robert E. Lanford

Researcher at Texas Biomedical Research Institute

Publications -  118
Citations -  10526

Robert E. Lanford is an academic researcher from Texas Biomedical Research Institute. The author has contributed to research in topics: Virus & Hepatitis C virus. The author has an hindex of 51, co-authored 118 publications receiving 9863 citations. Previous affiliations of Robert E. Lanford include University of Texas Health Science Center at San Antonio.

Papers
More filters
Journal ArticleDOI

Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection

TL;DR: Treatment of chronically infected chimpanzees with a locked nucleic acid (LNA)–modified oligonucleotide (SPC3649) complementary to miR-122 leads to long-lasting suppression of HCV viremia, with no evidence of viral resistance or side effects in the treated animals.
Journal ArticleDOI

A pathogenic picornavirus acquires an envelope by hijacking cellular membranes

TL;DR: It is shown that HAV released from cells is cloaked in host-derived membranes, thereby protecting the virion from antibody-mediated neutralization, and blurs the classic distinction between ‘enveloped’ and ‘non-envelope’ viruses and has broad implications for mechanisms of viral egress from infected cells as well as host immune responses.
Journal ArticleDOI

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

TL;DR: It is reported here that HCVcc strain FL-J6/JFH can establish long-term infections in chimpanzees and in mice containing human liver grafts, and virus recovered from these animals was highly infectious in cell culture, demonstrating efficient ex vivo culture of HCV.
Journal ArticleDOI

DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection

TL;DR: The data suggest a biphasic mechanism of viral clearance dependent on both the innate and adaptive immune responses and provide insight into the response of the liver to a hepatotropic viral infection.
Journal ArticleDOI

GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees

TL;DR: The small molecule GS-9620 activates Toll-like receptor 7 signaling in immune cells of chimpanzees to induce clearance of HBV-infected cells and might be developed for treatment of patients with chronic HBV infection.